Following the recruitment of Founding Members of the Biomedical Discipline in 2006, the drive for membership growth has now been focused back on the normal routes including "Formal Training", "General Experience" and "Mature". Currently there are three organisations offering 14 places of Scheme "A" training programmes to university graduates in biomedical engineering. In addition to the promotion initiative to attract more organisations and manufacturers to offer training programmes, there are also continuous membership drive activities to recruit new members.

The rapid growth of biomedical engineering is expected to continue as evidenced by the optimistic forecast within the medical device industry. Such growth is intensified by the aging population and the heightened demand for quality of healthcare services. Indeed, biomedical engineering has gradually migrated from a macroscopic and systemic perspective to a microscopic and cellular one. One example is the recent research and development of novel diagnostic technologies due to the pandemic threats of SARS and avian flu, which aims at overcoming the challenging demand for high sensitivity, specificity and minimal turn-around time, and thus more efficient infectious disease control.